‘Buzz about AI’ lends to Linguamatics win

By Maggie Lynch

- Last updated on GMT

(Image: Getty/AndreyPopov)
(Image: Getty/AndreyPopov)

Related tags awards AI Natural Language Processing Data Data management

Linguamatics’ platform was recognized for its ability to generate insights from unstructured and semi-structured data.

Frost & Sullivan presented its Global Product Leadership Award to Linguamatics following the market acceptance of the company’s I2E NLP text mining platform, which enables users to integrate artificial intelligence (AI) into research operations.  Frost & Sullivan recognized the company after reviewing market offerings and capabilities for performance.

There is a huge buzz about AI at the minute, and health care and pharma organizations are struggling to work out what the best applications are, how they can get value, and who they should work with,” ​said Jane Reed, head of life science strategy at Linguamatics.

“At all stages, natural language processing, an AI technology, can be used to find the key facts buried in the unstructured text (literature, patents, internal reports, news feeds, patient forum, clinical trial reports, electronic medical records) and surface these in an easy-to-digest manner,”​ she told us.

According to Reed, the demand for sophisticated tools that can handle the data transformation of AI and natural language processing (NLP) will increase.

Frost & Sullivan stated that the platform’s flexibility of application was a key component of its recognition. I2E can be applied across gene-disease mapping and target identification, biomarker discovery, regulatory compliance management, drug safety, clinical trial analysis, drug patent landscape reporting and analysis, real-world data analysis, and identification of clinical care gaps.

I2E can extract and search language, and can be plugged into automated workflows for database operations. Linguamatics also recently built iScite, a software-as-a-service (SaaS) AI-based text analytics solution using the company’s NLP technology. 

Related news

Show more

Related products

show more

The Right CDMO Can Unlock Faster Drug Development

The Right CDMO Can Unlock Faster Drug Development

Content provided by Lonza Small Molecules | 15-May-2023 | Interview

Drug development presents biotech companies with ever-changing challenges. Enabling a faster end-to-end process requires seamless flexibility and extensive...

SDTM supplemental qualifiers explained

SDTM supplemental qualifiers explained

Content provided by Formedix | 12-May-2023 | White Paper

What are SDTM supplemental qualifiers? In short, these are variables in non-CDISC datasets that cannot be mapped to a variable that matches the SDTM standard....

Plan for success with process liquid and buffer preparation

Plan for success with process liquid and buffer preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 25-Apr-2023 | White Paper

Setting the groundwork for successful scale-up is essential for getting a therapeutic to market quickly and efficiently, but navigating the unknowns associated...

Related suppliers

Follow us


View more